Amrize Ltd (NYSE:AMRZ) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

Key Points

• Consensus "Moderate Buy" — 17 analysts cover AMRZ (9 buy, 7 hold, 1 strong buy) with an average 12‑month price target of $64.14.
• Recent results: Amrize beat EPS expectations ($0.62 vs. $0.59) but missed revenue ($2.84B vs. $2.95B, down 0.4% YoY); the stock trades near $61.60 with a market cap of $34.07B and a P/E of 25.04.
• Insider and institutional buying — CFO Ian Johnston bought 1,200 shares at ~$63.92, while large institutions (Vanguard, Norges Bank, Dodge & Cox, Wellington) significantly increased or initiated positions.

Shares of Amrize Ltd (NYSE:AMRZ - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the seventeen ratings firms that are currently covering the stock, MarketBeat Ratings reports. Seven equities research analysts have rated the stock with a hold rating, nine have issued a buy rating and one has issued a strong buy rating on the company. The average 12 month price objective among brokers that have updated their coverage on the stock in the last year is $64.1429.

AMRZ has been the topic of several analyst reports. UBS Group raised their target price on Amrize from $53.00 to $57.00 and gave the company a "neutral" rating in a research report on Thursday, January 8th. Wells Fargo & Company raised their price target on Amrize from $59.00 to $66.00 and gave the company an "overweight" rating in a report on Thursday, February 19th. Weiss Ratings downgraded shares of Amrize from a "buy (b-)" rating to a "hold (c+)" rating in a report on Tuesday. Truist Financial increased their target price on shares of Amrize from $60.00 to $75.00 and gave the company a "buy" rating in a research report on Friday, February 20th. Finally, Bank of America set a $58.00 price target on shares of Amrize in a research report on Monday, January 12th.

Amrize Trading Down 1.8%

Amrize stock opened at $61.60 on Friday. The company has a quick ratio of 1.10, a current ratio of 1.64 and a debt-to-equity ratio of 0.37. The firm has a 50-day moving average price of $57.58 and a two-hundred day moving average price of $53.37. The firm has a market capitalization of $34.07 billion and a price-to-earnings ratio of 25.04. Amrize has a 52-week low of $44.12 and a 52-week high of $65.94.

Amrize (NYSE:AMRZ - Get Free Report) last announced its quarterly earnings results on Tuesday, February 17th. The company reported $0.62 EPS for the quarter, beating the consensus estimate of $0.59 by $0.03. The firm had revenue of $2.84 billion during the quarter, compared to analyst estimates of $2.95 billion. The business's quarterly revenue was down .4% compared to the same quarter last year.

Insider Buying and Selling

In other news, CFO Ian A. Johnston purchased 1,200 shares of the firm's stock in a transaction on Thursday, February 19th. The stock was purchased at an average cost of $63.92 per share, with a total value of $76,704.00. Following the purchase, the chief financial officer owned 18,544 shares in the company, valued at $1,185,332.48. This trade represents a 6.92% increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.

Institutional Trading of Amrize

Several institutional investors have recently modified their holdings of AMRZ. Vanguard Group Inc. grew its holdings in Amrize by 5.6% during the fourth quarter. Vanguard Group Inc. now owns 31,770,926 shares of the company's stock worth $1,722,500,000 after acquiring an additional 1,676,843 shares during the period. Norges Bank bought a new position in shares of Amrize during the 4th quarter valued at about $929,333,000. Dodge & Cox acquired a new position in shares of Amrize in the 2nd quarter worth approximately $622,085,000. Wellington Management Group LLP raised its holdings in shares of Amrize by 48.8% in the 3rd quarter. Wellington Management Group LLP now owns 11,622,024 shares of the company's stock worth $561,018,000 after purchasing an additional 3,809,133 shares in the last quarter. Finally, Harris Associates L P bought a new stake in shares of Amrize in the 4th quarter worth approximately $615,406,000.

Amrize Company Profile

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.